TISLELIZUMAB-JSGR: 50 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
50
Total FAERS Reports
11 (22.0%)
Deaths Reported
18
Hospitalizations
50
As Primary/Secondary Suspect
1
Life-Threatening
1
Disabilities
Prescription
Status
FDA Application: 761232 ·
First Report: 20220201 · Latest Report: 20250703
What Are the Most Common TISLELIZUMAB-JSGR Side Effects?
#1 Most Reported
Disease progression
15 reports (30.0%)
#2 Most Reported
Off label use
9 reports (18.0%)
#3 Most Reported
Pneumonia
8 reports (16.0%)
All TISLELIZUMAB-JSGR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 15 | 30.0% | 2 | 0 |
| Off label use | 9 | 18.0% | 2 | 1 |
| Anaemia | 8 | 16.0% | 1 | 1 |
| Pneumonia | 8 | 16.0% | 2 | 7 |
| Lymphadenopathy | 7 | 14.0% | 0 | 0 |
| Thrombocytopenia | 7 | 14.0% | 0 | 0 |
| Infusion related reaction | 6 | 12.0% | 0 | 6 |
| Pyrexia | 6 | 12.0% | 0 | 5 |
| Death | 5 | 10.0% | 5 | 0 |
Who Reports TISLELIZUMAB-JSGR Side Effects? Age & Gender Data
Gender: 53.5% female, 46.5% male. Average age: 63.3 years. Most reports from: GB. View detailed demographics →
Is TISLELIZUMAB-JSGR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2022 | 3 | 0 | 0 |
| 2024 | 6 | 0 | 6 |
| 2025 | 3 | 2 | 3 |
What Is TISLELIZUMAB-JSGR Used For?
Official FDA Label for TISLELIZUMAB-JSGR
Official prescribing information from the FDA-approved drug label.